CHARLES SCHWAB INVESTMENT MANAGEMENT INC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 220 filers reported holding FIBROGEN INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$180,469
-90.3%
209,142
-69.8%
0.00%
-100.0%
Q2 2023$1,869,456
-84.9%
692,391
+4.6%
0.00%
-75.0%
Q1 2023$12,357,249
+15.4%
662,232
-0.9%
0.00%
+33.3%
Q4 2022$10,709,098
+25.8%
668,483
+2.2%
0.00%0.0%
Q3 2022$8,510,000
+30.3%
654,102
+5.8%
0.00%
+50.0%
Q2 2022$6,531,000
-13.4%
618,408
-1.5%
0.00%0.0%
Q1 2022$7,543,000
-12.4%
627,517
+2.8%
0.00%
-33.3%
Q4 2021$8,609,000
+52.6%
610,516
+10.6%
0.00%
+50.0%
Q3 2021$5,640,000
-74.4%
551,823
-33.4%
0.00%
-71.4%
Q2 2021$22,049,000
-21.1%
827,948
+2.9%
0.01%
-30.0%
Q1 2021$27,939,000
-8.8%
804,904
-2.6%
0.01%
-16.7%
Q4 2020$30,643,000
-8.0%
826,153
+2.0%
0.01%
-20.0%
Q3 2020$33,313,000
+2.9%
810,120
+1.5%
0.02%
-6.2%
Q2 2020$32,364,000
+24.1%
798,505
+6.4%
0.02%
+6.7%
Q1 2020$26,081,000
-18.5%
750,525
+0.6%
0.02%
-11.8%
Q4 2019$32,006,000
+19.6%
746,214
+3.1%
0.02%
+6.2%
Q3 2019$26,761,000
-14.0%
723,652
+5.0%
0.02%
-15.8%
Q2 2019$31,127,000
-10.0%
688,947
+8.3%
0.02%
-13.6%
Q1 2019$34,582,000
+26.0%
636,282
+7.3%
0.02%
+4.8%
Q4 2018$27,441,000
-20.9%
592,915
+3.9%
0.02%
-8.7%
Q3 2018$34,680,000
+17.9%
570,862
+21.5%
0.02%
+9.5%
Q2 2018$29,404,000
+63.8%
469,708
+20.9%
0.02%
+50.0%
Q1 2018$17,955,000
+4.8%
388,634
+7.5%
0.01%0.0%
Q4 2017$17,139,000
-4.5%
361,564
+8.4%
0.01%
-12.5%
Q3 2017$17,951,000
+103.9%
333,660
+22.4%
0.02%
+100.0%
Q2 2017$8,805,000
+51.1%
272,574
+15.3%
0.01%
+33.3%
Q1 2017$5,827,000
+34.4%
236,373
+16.7%
0.01%
+20.0%
Q4 2016$4,335,000
+20.7%
202,533
+16.8%
0.01%
+25.0%
Q3 2016$3,591,000
+19.0%
173,440
-5.6%
0.00%0.0%
Q2 2016$3,017,000
-17.9%
183,822
+6.5%
0.00%
-20.0%
Q1 2016$3,674,000
-28.6%
172,546
+2.2%
0.01%
-28.6%
Q4 2015$5,146,000
+66.8%
168,864
+20.0%
0.01%
+40.0%
Q3 2015$3,085,000
+70.3%
140,699
+82.6%
0.01%
+66.7%
Q2 2015$1,811,000
+187.5%
77,037
+284.1%
0.00%
+200.0%
Q1 2015$630,000
+19.5%
20,054
+4.2%
0.00%0.0%
Q4 2014$527,00019,2420.00%
Other shareholders
FIBROGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders